The structure of the Orm2-containing serine palmitoyltransferase complex reveals distinct inhibitory potentials of yeast Orm proteins
Authors:
- Carolin KörnerCKCarolin Körner
- Jan-Hannes SchäferJSJan-Hannes Schäfer
- Bianca M. EschBEBianca M. Esch
- Kristian PareyKPKristian Parey
- Stefan WalterSWStefan Walter
- David TeisDTDavid Teis
- Dovile JanulieneDJDovile Januliene
- Oliver SchmidtOSOliver Schmidt
- Arne MoellerAMArne Moeller
- Florian FröhlichFFFlorian Fröhlich
Preprint
Abstract
Summary: The levels of sphingolipids are crucial determinants of neurodegenerative disorders. Therefore, sphingolipid levels have to be tightly regulated. The Orm protein family and ceramides act as inhibitors in the rate-limiting step of sphingolipid biosynthesis – the condensation of L-serine and palmitoyl-CoA. The two yeast isoforms Orm1 and Orm2 form a complex with the serine palmitoyltransferase (SPT). While the sequences of the Orm proteins are highly similar, however, Orm1 and Orm2 are differentially regulated in yeast cells. The mechanistic details of the differential regulation remain elusive. To elucidate the regulatory mechanism, we determined the cryo-electron microscopy structure of the SPT complex containing Orm2. Through in vitro activity assays and a newly developed plasmid coverage assay combined with targeted lipidomics, we demonstrate that the SPT complex with Orm2 exhibits lower activity in comparison to the complex containing Orm1. This collectively suggests a higher inhibitory potential of Orm2, despite the remarkably similar structures of the Orm1- and Orm2 containing complexes. The high conservation of the SPT from yeast to man implies that the three human ORMDL isoforms could also have different regulatory capacities, which might be essential to understanding their role in sphingolipid-mediated neurodegenerative disorders. Highlights: Cryo-EM structures of serine palmitoyltransferase with Orm2 from S. cerevisiae Ceramide-mediated inhibition on SPT activity is conserved amongst SPTs The two yeast Orm isoforms have different regulatory capacityKeywords
All Related Versions
- Published version: Cell Reports, 43 (8), 114627.
This publication has 68 references indexed in Scilit:
- Andromeda: A Peptide Search Engine Integrated into the MaxQuant EnvironmentJournal of Proteome Research, 2011
- Mutations in the SPTLC2 Subunit of Serine Palmitoyltransferase Cause Hereditary Sensory and Autonomic Neuropathy Type IThe American Journal of Human Genetics, 2010
- Orm family proteins mediate sphingolipid homeostasisNature, 2010
- Identification of small subunits of mammalian serine palmitoyltransferase that confer distinct acyl-CoA substrate specificitiesProceedings of the National Academy of Sciences, 2009
- Identification and characterization ofSMPD1mutations causing Niemann-Pick types A and B in Spanish patientsHuman Mutation, 2009
- Global analysis of the yeast lipidome by quantitative shotgun mass spectrometryProceedings of the National Academy of Sciences, 2009
- MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantificationNature Biotechnology, 2008
- Pkh‐kinases control eisosome assembly and organizationThe EMBO Journal, 2007
- Inference of Macromolecular Assemblies from Crystalline StateJournal of Molecular Biology, 2007
- Significance analysis of microarrays applied to the ionizing radiation responseProceedings of the National Academy of Sciences, 2001